See also this year's filing and all EDGAR filings for this company.
PDF Report 0001080709_2017_ARENA_PHARMACEUTICALS_INC.pdf
Logs
| warning | Missing logo | subcommand.report | {} |
| warning | Large missing amount for aggregate "Revenues" added to remainder. | industry.us_generic | {'missing_ratio': 3.0676881685149944, 'aggregate_val': 123975000, 'exp_sum': 30478000, 'exp_to_value': {'remainder_Revenues': 30478000}} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('stock_price')"} |
Graph
Absolute values for 0001080709, ARENA PHARMACEUTICALS INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 119,889,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 2,357,000 |
| 2 | PropertyPlantAndEquipmentNet | 43,828,000 |
| 3 | remainder_Assets | 2,936,000 |
| 4 | LiabilitiesCurrent | 63,879,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 31,243,000 |
| 9 | ResearchAndDevelopmentExpense | 66,425,000 |
| 10 | remainder_Expenses | 43,453,000 |
| 11 | remainder_Revenues | 123,975,000 |
| 12 | remainder_NetIncome | -5,750,000 |
| 13 | remainder_ComprehensiveNetIncome | -1,540,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 169,010,000 |
| 1 | Liabilities | 63,879,000 |
| 2 | Expenses | 141,121,000 |
| 3 | Revenues | 123,975,000 |
| 4 | StockholdersEquity | 105,131,000 |
| 5 | NetIncome | -22,896,000 |
| 6 | ComprehensiveNetIncome | -23,666,000 |
| 7 | BaseVar | 252,637,500 |
| 8 | EconomicCapitalRatio | 1.35 |
Edgar->Model Mapping
Feature Distribution
